Israel's XTEND is going public on Nasdaq through a $1.5 billion reverse merger

XTEND, an Israeli software company that lets a single operator command air, ground, and maritime robots in environments where GPS is jammed or unavailable, is going public on the Nasdaq through a $1.5 billion all-stock reverse merger with JFB Construction Holdings. The deal, announced July 27, 2026, will rebrand the combined company as XTEND AI Robotics, trading under the ticker XTND. Aviv Shapira will lead the combined company. Closing is targeted for mid-2026, subject to regulatory approval and customary conditions, according to the JFB Form 8-K.

A reverse merger lets a private company go public by absorbing into a shell that is already listed. XTEND shareholders will end up with about 70% of the combined company on a fully diluted basis, and JFB shareholders with 30%, excluding certain future equity incentive plans. Because the deal is all-stock, no cash changes hands; the $1.5 billion figure is a paper valuation on a public vehicle, not a transaction price. That structure is what makes the deal a reference point. Other Israeli and European defense-AI startups that struggle to clear U.S. procurement gatekeeping as private foreign companies now have a signed template: pair with a small U.S. public shell, swap equity, rebrand, and trade on Nasdaq.

The software behind the listing is the XTEND Operating System, or XOS. It sits between a human operator and a mixed fleet of small uncrewed systems and decides how tasks get handed off among them. XTEND ships the system alongside its own hardware: the Scorpio 1000 multi-domain platform and a small-aircraft line that includes the Wolverine, Griffon, and XTENDER. U.S. and Israeli forces field the technology, and allied units in Europe, Singapore, and the United Kingdom also operate it, according to the DroneLife announcement. That customer list is the asset XTEND brings to the Nasdaq: a software-defined path into contested environments where the operator count is small, the airspace is denied, and the procurement officer wants a U.S.-listed counterparty.

XTEND is not new to the U.S. market. The company opened a headquarters and manufacturing facility in Tampa, Florida in July 2025, a footprint it can point to when allied procurement officers ask whether the listing entity is American enough to buy. The Tampa site is both the U.S. manufacturing beachhead and the public-companies address.

The merger formalizes a structure first signaled in February 2026, when XTEND and JFB announced the reverse-merger template alongside a strategic investment round that included Eric Trump. Form 425 filings on SEC EDGAR document the communications around the deal. That early round is the bridge between the rumored template and the signed transaction.

The honest counterargument is structural. JFB is a small construction firm with no operational synergies to an autonomous-systems software company, and reverse mergers were the listing mechanism of the SPAC era before falling out of favor. The $1.5 billion figure is paper value on a public vehicle with no operating history in defense, and the 70/30 split can shift if equity grants expand before close. The mechanism story stands or falls on a concrete test: whether a Nasdaq listing actually clears the allied-procurement gatekeeping that a private Israeli defense-AI startup otherwise has to navigate one contract at a time.

The next milestone is a regulatory green light. XTEND and JFB have set a mid-2026 close target, but the deal is subject to standard closing conditions and the customary SEC and Nasdaq reviews for a reverse merger. The first proof point will be whether the merged entity books allied-procurement revenue at the scale the listing structure implies, and whether another defense-AI startup reuses the template.